ω-3 fatty acid supplements in women at high risk of breast cancer have dose-dependent effects on breast adipose tissue fatty acid composition

American Journal of Clinical Nutrition

Volumn 91, Issue 5, 2010, Pages 1185-1194

  Yee, Lisa D ^a   Lester, Joanne L ^a   Cole, Rachel M ^a   Richardson, Julia R ^a   Hsu, Jason C ^a   Li, Yan ^a   Lehman, Amy ^a   Belury, Martha A ^a   Clinton, Steven K ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMEGA 3 FATTY ACID;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; BREAST CANCER; CANCER RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; HIGH RISK POPULATION; HUMAN; LIPID COMPOSITION; OPEN STUDY; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE FUNCTION; UNSPECIFIED SIDE EFFECT;

ADIPOSE TISSUE; ADULT; AGED; ALANINE TRANSAMINASE; BIOPSY; BLOOD PLATELETS; BODY MASS INDEX; BREAST; BREAST NEOPLASMS; DIETARY FATS; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; EICOSAPENTAENOIC ACID; FAMILY; FATTY ACIDS; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; HYPERPLASIA; LIPIDS; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; RANDOM ALLOCATION; WAIST-HIP RATIO;

EID: 77951961615     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.3945/ajcn.2009.29036     Document Type: Article

References (34)

1. Pritchard GA, Jones DL, Mansel RE. Lipids in breast carcinogenesis. Br J Surg 1989;76:1069-1073
2. Gonzalez MJ, Schemmel RA, Gray JI, Dugan L, Sheffield LG, Welsch CW. Effect of dietary fat on growth of MCF-7 and MDA-MB-231 human breast carcinomas in athymic nude mice: relationship between carcinoma growth and lipid peroxidation product levels. Carcinogenesis 1991;12:1231-1235
3. Rose DP, Connolly JM. Effects of dietary omega-3 fatty acids on human breast cancer growth and metastases in nude mice. J Natl Cancer Inst 1993;85:1743-1747
4. Petrek JA, Hudgins LC, Levine B, Ho MN, Hirsch J. Breast cancer risk and fatty acids in the breast and abdominal adipose tissues. J Natl Cancer Inst 1994;86:53-56 (Pubitemid 24018386)
5. London SJ, Sacks FM, Stampfer MJ, et al. Fatty acid composition of the subcutaneous adipose tissue and risk of proliferative benign breast disease and breast cancer. J Natl Cancer Inst 1993;85:785-793
6. Eid A, Berry EM. The relationship between dietary fat, adipose tissue composition, and neoplasms of the breast. Nutr Cancer 1988;11:173-177
7. Zhu ZR, Agren J, Maennistoe S, et al. Fatty acid composition of breast adipose tissue in breast cancer patients and in patients with benign breast disease. Nutr Cancer 1995;24:151-160
8. Saadatian-Elahi M, Norat T, Goudable J, Riboli E. Biomarkers of dietary fatty acid intake and the risk of breast cancer: a meta-analysis. Int J Cancer 2004;111:584-591 (Pubitemid 39045326)
9. MacLean CH, Newberry SJ, Mojica WA, et al. Effects of omega-3 fatty acids on cancer risk. JAMA 2006;295:403-415
10. Chen YQ, Berquin IM, Daniel LW, et al. Omega-3 fatty acids and cancer risk. JAMA 2006;296:282. (Pubitemid 44079310)
11. Wigmore SJ, Ross JA, Falconer JS, et al. The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. Nutrition 1996;12:S27-30.
12. Burns CP, Halabi S, Clamon G, et al. Phase II study of high-dose fish oil capsules for patients with cancer-related cachexia-a Cancer and Leukemia Group B Study. Cancer 2004;101:370-378 (Pubitemid 38890842)
13. Bagga D, Capone S, Wang HJ, et al.Dietarymodulation of omega-3/omega-6 polyunsaturated fatty acid ratios in patients with breast cancer. J Natl Cancer Inst 1997;89:1123-1131 (Pubitemid 27337926)
14. Aronson WJ, Glaspy JA, Reddy ST, Reese D, Heber D, Bagga D. Modulation of omega-3/omega-6 polyunsaturated ratios with dietary fish oils in men with prostate cancer. Urology 2001;58:283-288 (Pubitemid 32728082)
15. Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 2002;21:495-505. (Pubitemid 36026261)
16. Geusens P, Wouters C, Nijs J, Jiang YD. J. Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis. a 12 month, double-blind, controlled study. Arthritis Rheum 1994;37:824-829 (Pubitemid 24184532)
17. Kremer JM, Lawrence DA, Jubiz W, et al. Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis. Clinical and immunologic effects. Arthritis Rheum 1990;33:810-820
18. Burns CP, Halabi S, Clamon G, et al. Phase I clinical study of fish oil fatty acid capsules for patients with cancer cachexia: Cancer and Leukemia Group B Study 9473. Clin Cancer Res 1999;5:3942-3947 (Pubitemid 30013768)
19. Burr ML, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 1989;2:757-761
20. Investigators of the GISSI-Prevenzione trial. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999;354: 447-455
21. Singh RB, Niaz MA, Sharma JP, Kumar R, Rastogi V, Moshiri M. Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival-4. Cardiovasc Drugs Ther 1997; 11:485-491 (Pubitemid 27367714)
22. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989;81:1879-1886
23. Belury MA, Kempa-Steczko A. Dietary conjugated linoleic acid modulates hepatic lipid composition in mice. Lipids 1997;32:199-204. (Pubitemid 27093193)
24. Hsu JC. Multiple comparisons: theory and methods. London, United Kingdom: Chapman and Hall, 1996.
25. Hsu JC, Berger R. Stepwise confidence intervals without multiplicity adjustment for dose response and toxicity studies. J Am Stat Assoc 1999;94:468-482
26. Hogg RJ, Fitzgibbons L, Atkins C, Nardelli N, Bay RC, Group NAINS. Efficacy of omega-3 fatty acids in children and adults with IgA nephropathy is dosage- and size-dependent. Clin J Am Soc Nephrol 2006; 1:1167-1172
27. Katan MB, Deslypere JP, van Birgelen APJM, Penders M, Zegwaard M. Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study. J Lipid Res 1997;38:2012-2022 (Pubitemid 27468010)
28. Kabir M, Skurnik G, Naour N, et al. Treatment for 2 mo with n-3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study. Am J Clin Nutr 2007;86: 1670-1679 (Pubitemid 350232182)
29. Damsgaard CT, Frøkiaer H, Andersen AD, Lauritzen L. Fish oil in combination with high or low intakes of linoleic acid lowers plasma triacylglycerols but does not affect other cardiovascular risk markers in healthy men. J Nutr 2008;138:1061-1066
30. Vedin I, Cederholm T, Levi YF, et al. Effects of docosahexaenoic acid-rich n-3 fatty acid supplementation on cytokine release from blood mononuclear leukocytes: the OmegAD study. Am J Clin Nutr 2008;87:1616-1622
31. Giltay EJ, Gooren LJG, Toorians AWFT, Katan MB, Zock PL. Docosahexaenoic acid concentrations are higher in women than in men because of estrogenic effects. Am J Clin Nutr 2004;80:1167-1174
32. Giltay EJ, Duschek EJJ, Katan MB, Zock PL, Neele SJ, Netelenbos JC. Raloxifene and hormone replacement therapy increase arachidonic acid and docosahexaenoic acid levels in postmenopausal women. J Endocrinol 2004;182:399-408.
33. Bønaa KH, Bjerve KS, Straume B, Gram IT, Thelle D. Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension. A population-based intervention trial from the Tromsø study. N Engl J Med 1990;322:795-801.
34. Meyer BJ, Hammervold T, Rustan AC, Howe PR. Dose-dependent effects of docosahexaenoic acid supplementation on blood lipids in statin-treated hyperlipidaemic subjects. Lipids 2007;42:109-115